Alembic Pharma gets USFDA nod

Blog | Morning Update

Good morning!

Here are the top stories to start your day.


For more updates on F&O. Click here.


Alembic Pharma gets USFDA nod

The pharma company has received USFDA approval for a new drug, Brimonidine Tartrate Ophthalmic Solution. As per IQVIA, this solution has an estimated market size of $97 million for the twelve months ended December 2022.  

 

⭐ Sansera Engg. does new investment 

The engineering firm has announced a new strategic investment in MMRFIC Technology. Sansera Engineering will invest ₹20 crore for a 21% stake in the design and manufacturing firm, with an option to invest further. The company has entered the high technology space, through this investment, including defence and aerospace.

 

⭐ Shree Renuka expands ethanol capacity 

The sugar producer said it has commenced commercial ethanol production at two plants. As per management, the company has expanded its ethanol capacity from 520 kilo litre per day (KLPD) to 1,250 KLPD.


Global markets (at 9:30 AM today)

Indices Today's movement
SGX Nifty 1.03%
Nikkei 225 (Japan) ▲ 0.92%
Hang Seng (Hong Kong) ▲ 0.45%
SSE Composite (China) ▲ 0.35%
Dow Jones (US) (March 30) ▲ 0.43%
NYSE (US) (March 30) ▲ 0.31%
Nasdaq (US) (March 30) ▲ 0.73%
S&P 500 (US) (March 30) ▲ 0.57%

Fact of the day

Since starting its overseas exports in 1986, Maruti Suzuki has crossed the 25 lakh units milestone of cumulative exports on Wednesday.

Source: Live Mint
Download IconDownload the Upstox App Today